Suppr超能文献

可乐定特异性抗血清可识别脑中一种内源性可乐定置换物质。

Clonidine-specific antisera recognize an endogenous clonidine-displacing substance in brain.

作者信息

Meeley M P, Towle A C, Ernsberger P, Char L K, McCauley P M, Reis D J

机构信息

Division of Neurobiology, Cornell University Medical College, New York, New York 10021.

出版信息

Hypertension. 1989 Apr;13(4):341-51. doi: 10.1161/01.hyp.13.4.341.

Abstract

An endogenous substance in brain, clonidine-displacing substance, binds to the same receptor populations as clonidine and is biologically active. Since receptor binding sites can be modeled by using specific antiligand antibodies, we tested the hypothesis that polyclonal antibodies raised in rat and rabbit against the clonidine analog p-aminoclonidine coupled to hemocyanin would recognize compounds structurally related to clonidine, including clonidine-displacing substance. Binding to anti-p-aminoclonidine antibodies was examined by using a competitive radioimmunoassay with tritiated p-aminoclonidine as the radioligand. Central vasodepressor agents that, like clonidine, are known to bind with high affinity to both imidazole sites and alpha 2-adrenergic receptors in brain inhibited radioligand binding to anti-p-aminoclonidine antibodies. All of these agents contain imidazol(in)e and phenyl ring moieties as part of their chemical structures (e.g., oxymetazoline); a number of other compounds without one or both of these rings failed to cross-react with the antisera. Clonidine-displacing substance, partially purified from bovine brain, also inhibited specific radioligand binding to anti-p-aminoclonidine antibodies. The inhibition was dose dependent and high affinity (IC50, 4 Units). The endogenous substance had no effect on the apparent affinity of the antibodies for the radioligand, but blocked a specific number of binding sites. Immunoprecipitation experiments showed that authentic clonidine-displacing substance, that which displaces tritiated p-aminoclonidine binding to membrane receptors, is recognized by anti-p-aminoclonidine antibodies. We conclude that a unique subset of structural determinants required for ligand interaction with both imidazole and alpha 2-adrenergic receptors is critical for binding to anti-p-aminoclonidine antibodies, and that since clonidine-displacing substance is recognized by highly clonidine-specific antisera, it may also contain these determinants within its structure, namely the imidazol(in)e and phenyl ring systems.

摘要

脑内的一种内源性物质——可乐定置换物质,与可乐定结合于相同的受体群体,且具有生物活性。由于受体结合位点可用特异性抗配体抗体进行模拟,我们检验了以下假说:用与血蓝蛋白偶联的可乐定类似物对氨基可乐定在大鼠和兔体内制备的多克隆抗体,能够识别与可乐定结构相关的化合物,包括可乐定置换物质。采用以氚标记的对氨基可乐定作为放射性配体的竞争性放射免疫分析法,检测与抗对氨基可乐定抗体的结合情况。已知与可乐定一样,能与脑内咪唑位点和α2-肾上腺素能受体高亲和力结合的中枢血管降压药,抑制了放射性配体与抗对氨基可乐定抗体的结合。所有这些药物的化学结构中都含有咪唑(啉)和苯环部分(如羟甲唑啉);许多其他不含这一个或两个环的化合物不能与抗血清发生交叉反应。从牛脑部分纯化得到的可乐定置换物质,也抑制放射性配体与抗对氨基可乐定抗体的特异性结合。这种抑制呈剂量依赖性且具有高亲和力(半数抑制浓度,4单位)。该内源性物质对抗体与放射性配体的表观亲和力没有影响,但封闭了一定数量的结合位点。免疫沉淀实验表明,能置换氚标记的对氨基可乐定与膜受体结合的真正的可乐定置换物质,可被抗对氨基可乐定抗体识别。我们得出结论,配体与咪唑和α2-肾上腺素能受体相互作用所需的独特结构决定簇子集,对于与抗对氨基可乐定抗体的结合至关重要,而且由于可乐定置换物质能被高度特异性的可乐定抗血清识别,其结构中可能也含有这些决定簇,即咪唑(啉)和苯环系统。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验